Keith Westby - Mar 16, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP & COO
Signature
/s/ Todd Anderman, as attorney-in-fact for Keith Westby
Stock symbol
ISEE
Transactions as of
Mar 16, 2022
Transactions value $
-$150,190
Form type
4
Date filed
3/18/2022, 04:21 PM
Previous filing
Mar 2, 2022
Next filing
Apr 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Sale -$118K -7.86K -6.6% $15.01 111K Mar 16, 2022 Direct F1, F2, F3
transaction ISEE Common Stock Sale -$32.3K -2.14K -1.93% $15.06 109K Mar 17, 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.0000 to $15.0300 per share on March 16, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3 This total includes 679 shares acquired by the Reporting Person on March 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F4 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.0000 to $15.1400 per share on March 17, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.